C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 19/056 (2006.01) A61K 31/70 (2006.01) A61P 31/12 (2006.01)
Patent
CA 2346447
A method for treating a patient having chronic hepatitis C infection to eradicate detectable HCV-RNA involving a combination therapy using a therapeutically effective amount of ribavirin derivative of formula (I) and a therapeutically effective amount of interferon-alpha for a time period of from 20 up to 80 weeks.
Méthode de traitement d'un patient atteint d'hépatite C chronique, destinée à supprimer l'ARN de VHC, qui consiste à administrer une quantité thérapeutiquement efficace de ribavirine de formule (I) en combinaison avec une quantité thérapeutiquement efficace d'interféron-alpha, sur une période qui s'étend de 20 à 80 semaines.
Bennett Frank
Ganguly Ashit K.
Girijavallabhan Viyyoor M.
Lovey Raymond G.
Mccormick Jinping
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Ribavirin-interferon alfa combination therapy for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ribavirin-interferon alfa combination therapy for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ribavirin-interferon alfa combination therapy for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1535983